Massarotti, E.M., "Medical Aspects of Rheumatoid Arthritis: Diagnosis and Treatment," Oncology, 12(3):463-475(1996). |
Harris, E.D., "Rheumatoid Arthritis: Pathophysiology and Implications for Therapy," N. Engl. J. Med., 332(18):1277-1289(1990). |
Beckwith, M., et al., "Growth Inhibition of Human Lymphoma Cell Lines by the Marine Products, Dolastatins 10 and 15," J. Natl. Cancer Inst., 85(6):483-488(1993). |
Galeotti, N., et al., "Formation of Oxazolines and Thiazolines in Peptides by the Mitsunobu Reaction," Tetrahedron Letters, 33(20):2807-2810(1992). |
Wipf, P., and Miller, C.P., "A Short, Stereospecific Synthesis of Dihydrooxazoles from Serine and Threonine Derivatives," Tetrahedron Letters, 33(7):907-910(1992). |
Tully, W.R., et al., "2-(Oxadiazolyl)- and 2-(Thiazolyl)imidazo[1,2-a]pyrimidines as Agonists and Inverse Agonists at Benzodiazepine Receptors," J. Med. Chem., 34:2060-2067(1991). |
Freidinger, R.M., et al., "Protected Lactam-Bridged Dipeptides for Use as Conformational Constraints in Peptides," J. Org. Chem., 47:104-109(1982). |
Pettit, G.R., et al., "Isolation and Structure of the Cytostatic Linear Depsipeptide Dolastatin 15.sup.1a," J. Org. Chem., 54:6005-6006(1989). |
Bai, R., et al., "Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects on cellular microtubules," Biochem. Pharmacol. 43(12):2637-2645(1992). (Abstract 117:103735g from 1-Pharmacology, p. 41, 1992). |
Pettit, G.R., et al., "Antineoplastic Agents. 220. Synthesis of Natural (-)-Dolastatin 15.sup.1," J. Am. Chem. Soc., 113:6693-6695(1991). |
Banerjee, S., et al., "Influence of Complement C5 and V.sub..beta. T Cell Receptor Mutations on Susceptibility to Collagen-Induced Arthritis in Mice.sup.1," J. Immunol, 142(7):2237-2243(1989). |